EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A Prospective 1-Year Follow-up of Glycemic Status and C-Peptide Levels of COVID-19 Survivors with Dysglycemia in Acute COVID-19 Infection

David Tak Wai Lui, Chi Ho Lee, Ying Wong, Carol Ho Yi Fong, Kimberly Hang Tsoi, Yu Cho Woo, Kathryn Choon Beng Tan

Diabetes & Metabolism Journal · 2024

DOI: 10.4093/dmj.2023.0175 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes & Metabolism Journal, 2024. Verfasst von David Tak Wai Lui und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong. Hauptthemen laut MEDLINE: COVID-19, C-Peptide, Blood Glucose, Glycated Hemoglobin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Diabetes Hongkong, Li Ka Shing Medical Fellowship for Internal Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We evaluated changes in glycemic status, over 1 year, of coronavirus disease 2019 (COVID-19) survivors with dysglycemia in acute COVID-19.

Methods

COVID-19 survivors who had dysglycemia (defined by glycosylated hemoglobin [HbA1c] 5.7% to 6.4% or random glucose ≥10.0 mmol/L) in acute COVID-19 were recruited from a major COVID-19 treatment center from September to October 2020. Matched non-COVID controls were recruited from community. The 75-g oral glucose tolerance test (OGTT) were performed at baseline (6 weeks after acute COVID-19) and 1 year after acute COVID-19, with HbA1c, insulin and C-peptide measurements. Progression in glycemic status was defined by progression from normoglycemia to prediabetes/diabetes, or prediabetes to diabetes.

Results

Fifty-two COVID-19 survivors were recruited. Compared with non-COVID controls, they had higher C-peptide (P< 0.001) and trend towards higher homeostasis model assessment of insulin resistance (P=0.065). Forty-three COVID-19 survivors attended 1-year reassessment. HbA1c increased from 5.5%±0.3% to 5.7%±0.2% (P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19C-PeptideBlood GlucoseGlycated HemoglobinGlucose Tolerance TestPrediabetic StateHumansMaleFemaleMiddle AgedProspective StudiesFollow-Up StudiesAgedSARS-CoV-2Insulin ResistanceSurvivorsDisease ProgressionAdultInsulinHyperglycemiaDiabetes MellitusCase-Control Studies

Stichwörter der Autor:innen

C-peptideCOVID-19Diabetes mellitusInsulin resistanceInsulin secretionSARS-CoV-2

Substanzen

C-PeptideBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanInsulin

Autor:innen und Institutionen

  • Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong.

Förderung

  • Diabetes Hongkong
  • Li Ka Shing Medical Fellowship for Internal Medicine

Zitieren

APA

Lui, D. T. W., Lee, C. H., Wong, Y., Fong, C. H. Y., Tsoi, K. H., Woo, Y. C., & Tan, K. C. B. (2024). A Prospective 1-Year Follow-up of Glycemic Status and C-Peptide Levels of COVID-19 Survivors with Dysglycemia in Acute COVID-19 Infection. Diabetes & Metabolism Journal. https://doi.org/10.4093/dmj.2023.0175

Vancouver

Lui DTW, Lee CH, Wong Y, Fong CHY, Tsoi KH, Woo YC, et al. A Prospective 1-Year Follow-up of Glycemic Status and C-Peptide Levels of COVID-19 Survivors with Dysglycemia in Acute COVID-19 Infection. Diabetes & Metabolism Journal. 2024. doi:10.4093/dmj.2023.0175

BibTeX
@article{Lui2024,
  author = {Lui, David Tak Wai and Lee, Chi Ho and Wong, Ying and Fong, Carol Ho Yi and Tsoi, Kimberly Hang and Woo, Yu Cho and Tan, Kathryn Choon Beng},
  title = {A Prospective 1-Year Follow-up of Glycemic Status and C-Peptide Levels of COVID-19 Survivors with Dysglycemia in Acute COVID-19 Infection},
  journal = {Diabetes & Metabolism Journal},
  year = {2024},
  doi = {10.4093/dmj.2023.0175}
}
Kostenlos starten →